Sunovion CTH-302 – Oral Apomorphine vs. Apomorphine injection.

The aim of this research is to see how movement may be improved by taking oral Apomorphine and evaluate this method of delivery against the sub-cutaneous injection of Apomorphine which is currently available for people with Parkinson’s.

Who

25 people diagnosed with Parkinson’s. You must have a good response to Levodopa, which you should be taking at least 3 times a day and experience “OFF” periods.

What

You will first go through a screening process where you will be assessed for your suitability to take part in the full research trial. At this screening visit you will have the opportunity to ask questions, give your consent, and a range of assessments will be performed.

You will be required to take both oral Apomorphine and subcutaneous Apomorphine injection during the course of the study.